+90 216 456 82 12

Doç. Dr. Suna Yapalı
Doç. Dr. Suna Yapalı

Ad Soyad : SUNA YAPALI

Unvan : Doç. Dr.

Tıbbi Birim : Gastroenteroloji, Endoskopi, Anorektal Hastalıklar Merkezi

Üst Uzmanlık : Gastroenteroloji

Uzmanlık : İç Hastalıkları

Şube : Kadıköy Hastanesi

E-Posta : suna.yapali@acibadem.com.tr

Web Sitesi : 

 

EĞİTİM
2014 University of Michigan, Division of Gastroenterology and Hepatology, Ann Arbor, MI, ABD
2012 Ege Üniversitesi Tıp Fakültesi Gastroenteroloji
2008 Marmara Üniversitesi Tıp Fakültesi İç Hastalıkları
2001 İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi

İŞ DENEYİMİ
2014 - Halen Acıbadem Sağlık Grubu
2012 - 2014 University of Michigan, Division of Gastroenterology and Hepatology, Ann Arbor, MI, ABD
2009 - 2012 Ege Üniversitesi Tıp Fakültesi Gastroenteroloji Anabilim Dalı
2008 - 2009 Haydarpaşa Numune Eğitim ve Araştırma Hastanesi, Gastroenteroloji Bölümü
2002 - 2008 Marmara Üniversitesi Tıp Fakültesi İç Hastalıkları Anabilim Dalı

ÜYELİKLER
American Gastroenterology Association
American Association for the Study of Liver Disease
European Association for the Study of Liver Disease
Türk Karaciğer Araştırmaları Derneği
Türk Gastroenteroloji Derneği
Ulusal İnflamatuvar Barsak Hastalıkları Derneği

YABANCI DİLLER
İngilizce

BİLİMSEL YAYINLAR
Management of Hepatitis B: My Practice and How it Relates to the Guidelines.
Clin Gastroenterol Hepatol 2014;12(1):16-26. Yapali S, Talaat N, Lok AS.

Outcome of chronic hepatitis B patients who do not meet criteria for antiviral treatment at presentation.
Clin Gastroenterol Hepatol 2014 Jul 17. pii: S1542- 3565(14)01048-9. doi: 10.1016/j.cgh.2014.07.019. Yapali S, Talaat N, Fontana RJ, Oberhelman K, Lok AS.

The potential benefit of telbivudine does not outweigh its high rate of antiviral drug resistance and other adverse effects.
Gastroenterology 2014;146(1)15-9. Yapali S, Lok AS.

Does suppression of HBV replication by antiviral therapy confer the same benefit as host immune control of HBV?
Gut 2014, Apr 1. doi: 10.1136/gutjnl-2014-306935. Yapali S, Lok AS.

Should this patient be treated? Best practices in identifying cirrhosis and HCC in patients infected with HBV ? Role of prediction models.
Johns Hopkins Medicine eViralHepatitis Review 2012, Volume 3, Issue 3. Yapali S, Lok AS.

Giant esophageal lipoma presenting with gastroesophageal reflux symptoms.
J Gastrointestinal Liver Diseases 2013;22(1):8. Yapali S, Oruc N, Harman M, Aydin A.

A severe case of esophageal ulcer causing a tight stricture despite long-term D-penicillamine treatment.
Wiener Klin Wochenschr 2014 Yapali S, Turan I, Ozutemiz O, Tekesin O.

Sexual activity does not predispose to reflux episodes in patients with gastroesophageal reflux disease.
UEG Journal 2014 DOI: 10.1177/2050640614550851 Bor S, Valytova E, Yapali S, Yildirim E, Vardar R.

"Predictors of histologic progression and clinical outcomes for patients with chronic hepatitis C: A systematic review"
Aliment Pharmacol Ther 2014;40(8):863-79. doi: 10.1111/apt.12921. Konerman M, Yapali S, Lok AS.

Changes in the characteristics of Hepatitis C patients seen in a liver center in the United States during the last decade.
J of Viral Hepat 2014 2014 Oct 14. doi: 10.1111/jvh.12343. Talat N, Yapali S, Fontana RJ, Conjeevaram H, Lok AS.

Branşlar

Önemli Linkler

Ziyaretcilerim

11533394 Kişi ziyaret etti.